Pierluigi Macchioni Selected Research

Pierluigi Macchioni Research Topics

Disease

8	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 08/2013 - 04/2002
5	Psoriatic Arthritis 11/2020 - 08/2003
4	Giant Cell Arteritis (Horton Disease) 08/2013 - 10/2003
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 08/2009
2	Rheumatic Diseases (Rheumatism) 01/2022 - 12/2007
2	Inflammation (Inflammations) 01/2022 - 12/2021
2	Arthralgia (Joint Pain) 10/2020 - 04/2012
2	Shoulder Pain 04/2012 - 04/2012
2	Pain (Aches) 04/2012 - 04/2012
1	Arthritis (Polyarthritis) 01/2022
1	Uveitis 01/2022
1	Tenosynovitis 09/2018
1	Thrombosis (Thrombus) 05/2016
1	Fever (Fevers) 05/2016
1	Arteritis 05/2016
1	Cardiovascular Infections 07/2014
1	Axial Spondyloarthritis 07/2014
1	Rheumatoid Arthritis 07/2014
1	Crohn Disease (Crohn's Disease) 07/2014
1	Necrosis 07/2014
1	Anterior Uveitis 07/2014
1	Adult-Onset Still's Disease 07/2014
1	Retroperitoneal Fibrosis 09/2013
1	Vasculitis (Vasculitides) 08/2013
1	Disease Susceptibility (Diathesis) 05/2013
1	Edema (Dropsy) 07/2012
1	Myositis (Idiopathic Inflammatory Myopathies) 07/2012
1	Aortic Arch Syndromes (Aortic Arch Syndrome) 11/2003
1	Hypersensitivity (Allergy) 08/2003

Drug/Important Bio-Agent (IBA)

4	SteroidsIBA 12/2021 - 04/2003
4	Interleukin-6 (Interleukin 6)IBA 09/2013 - 04/2002
3	C-Reactive ProteinIBA 07/2014 - 04/2012
3	GlucocorticoidsIBA 09/2013 - 04/2002
2	Prednisone (Sone)FDA LinkGeneric 05/2016 - 12/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014 - 08/2003
2	Anti-Citrullinated Protein AntibodiesIBA 07/2014 - 04/2012
2	tocilizumab (atlizumab)FDA Link 07/2014 - 08/2013
2	Rheumatoid FactorIBA 07/2014 - 04/2012
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 08/2013 - 08/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2009 - 10/2003
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2005 - 04/2002
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2005 - 04/2003
2	Infliximab (Remicade)FDA Link 08/2003 - 04/2003
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2022
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022
1	RA 25IBA 09/2018
1	Hemoglobins (Hemoglobin)IBA 05/2016
1	ametantrone (HAQ)IBA 07/2014
1	cyclic citrullinated peptideIBA 07/2014
1	canakinumab FDA Link 07/2014
1	AntibodiesIBA 07/2014
1	Interleukin-17 (Interleukin 17)IBA 05/2013
1	Adalimumab (Humira)FDA Link 07/2012
1	Creatine Kinase (Creatine Phosphokinase)IBA 07/2012
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2009
1	Cytokine Receptor gp130IBA 08/2008
1	Etanercept (Enbrel)FDA Link 12/2007
1	OligonucleotidesIBA 11/2003
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2003
1	gamma-glutamylaspartic acidIBA 11/2003
1	Monoclonal AntibodiesIBA 08/2003
1	Antirheumatic Agents (DMARD)IBA 08/2003
1	Hormones (Hormone)IBA 04/2002

Therapy/Procedure

9	Therapeutics 11/2020 - 04/2003
1	Drug Therapy (Chemotherapy) 10/2020
1	Contraindications 09/2013